“…The technology, often requiring creative modifications, was used for epitope mapping of antibodies [114], screening for receptor agonists and antagonists [115,133,134], in vitro evolution of antibodies [116,117] and antibody surrogates in the form of randomized fragments on diverse scaffold proteins [118,119], discovery of enzyme substrates [120,121] and inhibitors [113,122,135], identifying functionally coupled proteins and analysis of protein-protein interactions [123,124], designing catalytic antibodies (abzymes) and enzymes with novel specificities [125], improving proteolytic and folding stability of muteins [126], vaccine design [131,132], and construction of gene delivery vehicles [127]. Protein ligands selected from phage libraries as well as whole recombinant phage have been used as affinity matrices in chromatographic techniques [128,129] and biosensing [130].…”